investigated functional lipoprotein nanoparticles in DLBCL via targeting both cellular cholesterol uptake and BCR-associated de novo cholesterol synthesis and achieved cellular cholesterol reduction and induced apoptosis in otherwise resistant ABC DLBCL cell lines (47). The gene discussed is BCR; the disease is diffuse large B-cell lymphoma.